Stay updated on Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.

Latest updates to the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded Revision: v3.5.0; Deleted Revision: v3.4.3.SummaryDifference0.0%

- Check32 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page. This appears to be a software/version bump with no visible changes to study content or user-facing features.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page now shows a minor site revision label 'Revision: v3.4.2' and removes the prior 'Revision: v3.4.1' label, including a government funding status notice.SummaryDifference0.2%

- Check67 days agoChange DetectedNew documents and external references were added to the study page, including the Study Protocol PDF, Statistical Analysis Plan PDF, IPD sharing information, and publications from PubMed.SummaryDifference98%

- Check74 days agoChange DetectedAdded: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; Deleted: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check88 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. No visible changes to content or functionality were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.